Protective role of Panax ginseng extract standardized with ginsenoside Rg3 against acrylamide-induced neurotoxicity in rats

Journal of Applied Toxicology

Volumn 26, Issue 3, 2006, Pages 198-206

  Mannaa, Fathia ^a   Abdel Wahhab, Mosaad A ^a   Ahmed, Hanaa H ^a   Park, Myung H ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b Ambo Institute   (South Korea)

Author keywords

Acrylamide; Antioxidant; Chemoprevention; Ginsenoside; Hormones; Neurotoxicity; Panax ginseng extract

Indexed keywords

ACRYLAMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); GINSENG EXTRACT; GINSENOSIDE RG 3; LACTATE DEHYDROGENASE; SUPEROXIDE DISMUTASE;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; FEMALE; LIOTHYRONINE BLOOD LEVEL; LIPID PEROXIDATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RAT; SEROTONIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ACRYLAMIDE; ADMINISTRATION, ORAL; ANIMALS; BRAIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; LIPID PEROXIDATION; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; PANAX; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; PANAX GINSENG;

EID: 33646827470     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1128     Document Type: Article

References (76)

1. Abd El-Aziem SH, Abdel-Wahhab MA, Mahmoud AM, Hassan AM, Mahrous KF. 2004. Chemoprevention of barley and sage against acrylamide-induced genotoxic, biochemical and histological alterations in rats. Egypt. J. Hosp. Med. 15: 40-56.
2. Abdel-Wahhab MA, Ahmed HH. 2004. Protective effects of Korean Panax ginseng against chromium VI toxicity and free radical generation in rats. J. Ginseng Res. 28: 11-17.
3. Ali SF, Hong JS, Wilson WE, Uphouse LL, Bondy SC. 1983. Effect of acrylamide on neurotransmitter metabolism and neuropeptide levels in several brain regions and upon circulating hormones. Arch. Toxicol. 52: 35-43.
4. Bayer MF, Kriss JP, McDougall IR. 1985. Clinical experience with sensitive thyroprotein measurements: diagnostic and therapeutic implication. J. Nucl. Med. 26: 1248-1256.
5. Bergmark E, Calleman CJ, Costa LG. 1991. Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol. Appl. Pharmacol. 111: 352-363.
6. Blake-Tyrrell J, Forsham PH. 1985. Glucocorticoids and adrenal androgens. In Basic and Clinical Endocrinology, Greenspan FS, Forsham PH (eds). Lang Medical: California; 272-309.
7. Bull RJ, Robinson M, Laurie RD, Stoner GD, Greisiger E, Meier JR, Stober JA. 1984a. Carcinogenic effects of acrylamide in sencar and a/j mice. Cancer Res. 44: 107-111.
8. Bull RJ, Robinson M, Stober JA. 1984b. Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett. 24: 202-212.
9. Carr BR. 1992. Disorders of the ovary and female reproductive tract. In Williams Textbook of Endocrinology, 8th edn, Wilson JD, Foster DW (eds). W. B. Saunders: Philadelphia; 733-798.
10. Cavanagh JB. 1982. The pathokinetics of acrylamide intoxication: a reassessment of the problem. Neuropathol. Appl. Neurobiol. 8: 315-336.
11. Charming CP, Schaerf FW, Anderson LD. 1980. Ovarian follicular and luteal physiology. In Reproductive Physiology III, Greep RO (ed.). University Park Press: Baltimore; 117.
12. Chatterly S, Sun T, Lien Y. 1991. Diagnostic value of lactate dehydrogenase isoenzymes in cerebrospinal fluid. J. Clin. Lab. Anal. 5: 168-174.
13. Dearfield KL, Douglas GR, Ehling UH, Moore MM, Sega GA, Brusick DJ. 1988. Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity and carcinogenicity. Mutat. Res. 195: 45-77.
14. Deng H, He S, Zhang S. 1993. Quantitative measurements of vibration threshold in healthy adults and acrylamide workers. Int. Arch. Occup. Environ. Health. 65: 53-56.
15. Endo A, Kinugawa T, Ogino K, Kato M, Hamada T, Osaki S, Igawa O, Hisatoma I. 2000. Cardiac and plasma catecholamine responses to exercise in patients with type 2 diabetes: prognostic implications for cardiac-cerebrovascular events. Am. J. Med. Sci. 320: 24-30.
16. Erdreich LS, Friedman MA. 2004. Epidemiologic evidence for assessing the carcinogenicity of acrylamide. Regul. Toxicol. Pharmacol. 39: 150-157.
17. Friedman M, Dulak L, Stedham M. 1995. A lifetime oncogenicity study in rats with acrylamide. Fundam. Appl. Toxicol. 27: 95-105.
18. He F, Zhang S, Wang H. 1989. Neurological and electroneuromyographic assessment of the adverse effects of acrylamide on occupationally exposed workers. Scand. J. Work Environ. Health 15: 125-129.
19. Hu SY. 1977. A contribution to our knowledge of ginseng. Am. J. Clin. Med. 5: 1-23.
20. IARC. 1994. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Some Industrial Chemicals. Lyon, 15-22 February 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 60: 1-560.
21. Joen BH, Kim CS, Park KS, Lee JW, Park JB, Kim KJ, Kim SH, Chang SJ, Nam KY. 2000. Effect of Korean red ginseng on blood pressure in conscious hypertensive rats. Gen. Pharmacol. 35: 135-141.
22. Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, Mast RW. 1986. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol. 85: 154-168.
23. Kachmar JF, Moss DW. 1976. In Fundamental Chemistry, 2nd edn, Tietz NW (ed.). W. B. Saunders: Philadelphia; 652.
24. Kema IP, Schellings AM, Meiborg G, Hoppenbrouwers CJ, Muskiet FA. 1992. Influence of serotonin- and dopamine- rich diet on platelet serotonin content and urinary excretion of biogenic amines and their metabolities. Clin. Chem. 38: 1730-1736.
25. Kennedy DO, Scholey AB, Wesnes KA. 2001. Dose dependent changes in cognitive performance and, mood to healthy young volunteers. Nutr. Neurosci. 4: 295-310.
26. Khan MA, Davis CA, Foley GL, Friedman MA, Hansen LG. 1999. Changes in thyroid gland after acute acrylamide exposure. Toxicol. Sci. 47: 151-157.
27. Kim HJ, Chun YJ, Park JD, Kim S, Roh JK, Jeong TC. 1997. Protective of rat liver microsomes against carbon tetrachlbride-induced lipid peroxidation by red ginseng saponin through cytochrome P450 inhibition. Planta Med. 63: 415-418.
28. Konoshima T, Takasaki M, Tokuda H, Nishino H, Duc NM, Kassai R, Yamasaki K. 1998. Anti-tumor-promoting activity of majonoside-R2 from vietnamese ginseng, Panax vietnamensis Ha et Grushv. (I). Biol. Pharm. Bull. 21: 834-838.
29. Kwon Y, Jang K. 2004. The effect of Korean red ginseng on liver regeneration after 70% hepatectomy in rats. J. Vet. Med. Sci. 66: 193-195.
30. Lang H. 1981. Creatine Kinase Isoenzymes: Pathophysiology and Clinical Application. Springer-Verlag: Berlin, Heidelberg.
31. Lehning EJ, Persaud A, Dyer KR, Jortner BS, LoPachin RM Jr. 1998. Biochemical and morphologic characterization of acrylamide peripheral neuropathy. Toxicol. Appl. Pharmacol. 151: 211-221.
32. +-ATPaSe identified as an ouabain binding site in rat sciatic nerve. Neurosci. Lett. 64: 177-183.
33. LoPachin RM. 2004. The changing view of acrylamide neurotoxicity. Neurotoxicology 25: 617-630.
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Polin phenol reagent. J. Biol. Chem. 193: 265-275.
35. Marsh GM, Lucas LJ, Youk AO, Schall LC. 1999. Mortality patterns among workers exposed to acrylamide: 1994 follow up. Occup. Environ. Med. 56: 181-190.
36. Matsuoka M, Matsumura H, Igisu H. 1996. Creatine kinase activities in brain and blood: possible neurotoxic indicator of acrylamide intoxication. Occup. Environ. Med. 53: 468-471.
37. Mei B, Wang YF, Wu JX, Chen WZ. 1994. Protective effects of ginsenosides on oxygen free radical induced damage of cultured vascular endothelial cells in vitro. Yao Xue Xue Bao 29: 801-808.
38. Ohnishi Y, Takagi S, Miura T, Usami M, Kako M, Ishihara E, Yano H, Tanigawa K, Seino Y. 1996. Effect of ginseng radix on GLUT2 protein content in mouse liver in normal and epinephrine-induced hyperglycemic mice. Biol. Pharm. Bull. 19: 1238-1240.
39. Orth DN, Koracs WJ, Bold CR. 1992. The adrenal cortex. In Williams Textbook of Endocrinology, 8th edn, Wilson JD, Foster DW (eds). W. B. Saunders: Philadelphia; 489-619.
40. Panwar M, Kumar M, Samarth R, Kumar A. 2005. Evaluation of chemopreventive action and antimutagenic effect of the standardized Panax ginseng extract, EFLA400, in swiss albino mice. Phytother. Res. 19: 65-71.
41. Parker LN. 1991. Control of adrenal androgen secretions. Endocrinol. Metab. Clin. 20: 401-422.
42. Patel HC, Boutin H, Allan SM. 2003. Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration. Ann. N. Y. Acad Sci. 992: 39-47.
43. Rai D, Bhatia G, Sen T, Palit G. 2003. Anti-stress effects of Ginkgo biloba and Panax ginseng: a comparative study. J. Pharmacol. Sci. 93: 458-464.
44. Ratcliffe WA, Carter GD, Dowsett M, Hillier SG, Middle JG, Reed MJ. 1988. Estradiol assays: Applications and guidelines for the provision of clinical biochemistry service. Ann. Clin. Biochem. 25: 466-483.
45. Robbins J. 1971. Thyroxin-binding protein in serum. In Laboratory Diagnosis of Endocrine Diseases, Sunderman FW and Sunderman FW Jr (eds). Warren H. Green Inc: St Louis, MO; 211.
46. Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, deGroot H. 1994. Antioxidant effects of estradiol and 2 hydroxyestradiol on iron induced lipid peroxidation of rat liver microsome. Steroid 59: 383-388.
47. SAS Institute. 1982. SAS User's Guide: Statistics. SAS Institute Inc: Cary., NC.
48. Schinella GR, Tournier HA, Prieto JM, Mordujovich de Buschiazzo P, Rios JL. 2002. Antioxidant activity of anti-inflammatory plant extracts. Life Sci. 70: 1023-1033.
49. Schwartz MK. 1982. Enzyme tests in cancer. Clin. Lab. Med. 2: 479-491.
50. Sega OG, Valdivia Alcota RP, Tancongco CP, Brimer PA. 1989. Acrylamide binding to the DNA and protamine of spermiogenic stages in the mouse and its relationship to genetic damage. Mutat. Res. 216: 221-230.
51. Shelby MD. 2004. NTP-CERHR Panel Report on the Reproductive and Developmental Toxicity of Acrylamide. Center for the Evaluation of Risks to Human Reproduction. National Toxicology Program, US Department of Health and Human Services. NTP-CERHR-Acrylamide-04.
52. Sickles DW, Fowler SR, Testino AR. 1990. Effects of neurofilamentous axonopathy-producing neurotoxicants on in vitro production of ATP by brain mitochondria. Brain Res. 528: 25-31.
53. SNFA. 2002. Swedish National Food Administration. Acrylamide in Food. Swedish National Food Administration: Uppsala.
54. Spencer PS, Schaumburg HH. 1974. A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms. Can. J. Neurol. Sci. 1: 170-192.
55. Spencer PS, Schaumburg HH. 1977a. Ultrastructural studies of the dying back process. III. The evolution of experimental peripheral gain axonal degeneration. J. Neuropathol. Exp. Neurol. 36: 276-299.
56. Spencer PS, Schaumburg, HH. 1977b. Ultrastructural studies of the dying back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathy. J. Neuropathol. Exp. Neurol. 36. 300-320.
57. Spencer PS, Schaumburg HH. 1979. Clinical and experimental studies of distal axonopathy: a frequent form of brain and nerve damage produced by environmental chemical hazards. N. Y. Acad. Sci. 329: 14-29.
58. Suh HW, Song DK, Kim YH. 1997. Effect of ginsenosides injected intrathecally or intracerebroventricularly on antinociception induced by morphine administrated intracerebroventricularly in the mouse. Gen. Pharmacol. 29: 873-877.
59. Suttle NF. 1986. Copper deficiency in ruminants, recent developments. Vet. Rec. 119: 519-522.
60. Szasz G, Gruber W, Bernt E. 1976. Creatine kinase in serum: 1-Determination of optimun reaction conditions. Clin. Chem. 22: 650-656.
61. Tachikawa E, Kudo K. 2004. Proof of the mysterious efficacy of ginseng: Basic and clinical trials: suppression of adrenal medullary function in vitro by ginseng. J. Pharmacol. Sci. 95: 140-144.
62. Tareke E, Ryber P, Karlsson P, Ericsson S, Tornqvest M. 2002. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J. Agric. Food Chem. 50: 4998-5006.
63. Tietz NW. 1987. Fundamental of Clinical Chemistry. Saunders Press: Philadelphia; 588.
64. Tietz NW. 1995. Clinical Guide to Laboratory Tests, 3rd edn. W. B. Saunders: Philadelphia.
65. +-ATPase inhibition induced by free radicals. Z. Naturforsch. 55: 271-277.
66. 2+ATPaSe activities induced by the in vitro galactosaemia. Pharmacol. Res. 49: 475-479.
67. Tyl RW, Friedman MA, Losco PE, Ross WP. 2000a. Rat two-generation reproduction and dominant lethal study of acrylamide in drinking water. Reprod. Toxicol. 14: 385-401.
68. Tyl RW, Marr MC, Myers CB, Ross WP, Friedman MA. 2000b. Relationship between acrylamide reproductive and neurotoxicity in male rats. Reprod. Toxicol. 14: 147-157.
69. Van Landingham CB, Lawrence GA, Shipp AM. 2004. Estimates of lifetime-absorbed daily doses from the use of personal-care products containing polyacrylamide: A Monte Carlo Analysis. Risk Anal. 24: 603-619.
70. Waller RA, Duncan DB. 1969. A Bayes rule for the symmetric multiple comparison problems. J. Am. Stat. Assoc. 64: 1484-1503.
71. Wisdom GP. 1976. Enzyme-immunoassay. Clin. Chem. 22: 1243-1255.
72. Working P, Bently K, Hurtt M, Mohr K. 1987. Comparison of the dominant lethal effects of acrylamide and acrylamide in male Fischer 344 rats. Mutagenesis 2: 215-220.
73. Xie ZC, Qian ZK, Lium ZW. 1993. Effect of ginseng on antiperoxidate injury in myocardium and erythrocytes in streptozotocin induced diabetic rats. Chung Kuo. Chung Hist. Chiech-Ho. Tsa-Chih 13: 289-290.
74. Yu W, Lee B, Nam S, Yang D, Yun Y. 2003. Modulating effects of Korean ginseng saponins on ovarian function in immature rats. Biol. Pharm. Bull. 26: 1574-1580.
75. Yun T-K. 2001. Panax ginseng - a non-organ-specific cancer preventive? Lancet Oncol. 2: 49-55.
76. Yun T-K. 2003. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat. Res. 523-524: 63-74.